Factors affecting patency of venous allografts in miniature swine

Scott Stevens, John D. Tyler, Michael Freeman, Fred Hopkins, Tammie Lewis, Joan Bray, Anne L. Edwards, Kelvin Brockbank, Mitchell Goldman

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

In immunologically defined National Institutes of Health miniswine, a segment of internal jugular vein was anastomosed to the carotid artery as an interposition graft. Patency of swine major histocompatibility complex matched, one haplotype mismatched, and complete mismatched veins was 9.8, 6.3, and 3.0 weeks respectively (p = 0.009). More than 90% of mismatched and 20% of matched allografts developed a positive crossmatch before occlusion (p = 0.006). The mixed lymphocyte response did not predict graft occlusion. Treatment of 10 swine with cyclosporine (10 mg/kg/day) did not significantly improve patency for one haplotype mismatched grafts. In haplotype mismatched veins, cryopreserved grafts occluded more rapidly than noncryopreserved grafts: mean 2.4 versus 6.3 weeks, respectively (p = 0.002). In all cryopreserved vein grafts, alloantibody appeared at or after graft occlusion rather than before occlusion as seen with fresh allografts (p = 0.046). The mean patency of cryopreserved versus fresh autografts was 3.3 and >32 weeks, respectively (p = 0.004). In summary, these results indicate that (1) allograft patency is related to the degree of swine major histocompatibility complex match and development of cytotoxic alloantibodies; (2) moderate-dose cyclosporine does not prolong allograft patency nor suppress development of antibody; (3) cryopreservation may accelerate graft occlusion through nonimmunologic mechanisms.

Original languageEnglish (US)
Pages (from-to)361-366
Number of pages6
JournalJournal of Vascular Surgery
Volume12
Issue number3
DOIs
StatePublished - Jan 1 1990

Fingerprint

Miniature Swine
Allografts
Transplants
Haplotypes
Isoantibodies
Veins
Swine
Major Histocompatibility Complex
Cyclosporine
Cryopreservation
Jugular Veins
Autografts
National Institutes of Health (U.S.)
Carotid Arteries
Lymphocytes
Antibodies

All Science Journal Classification (ASJC) codes

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Factors affecting patency of venous allografts in miniature swine. / Stevens, Scott; Tyler, John D.; Freeman, Michael; Hopkins, Fred; Lewis, Tammie; Bray, Joan; Edwards, Anne L.; Brockbank, Kelvin; Goldman, Mitchell.

In: Journal of Vascular Surgery, Vol. 12, No. 3, 01.01.1990, p. 361-366.

Research output: Contribution to journalArticle

Stevens, Scott ; Tyler, John D. ; Freeman, Michael ; Hopkins, Fred ; Lewis, Tammie ; Bray, Joan ; Edwards, Anne L. ; Brockbank, Kelvin ; Goldman, Mitchell. / Factors affecting patency of venous allografts in miniature swine. In: Journal of Vascular Surgery. 1990 ; Vol. 12, No. 3. pp. 361-366.
@article{27e148f226fb467dbb0a59622871a301,
title = "Factors affecting patency of venous allografts in miniature swine",
abstract = "In immunologically defined National Institutes of Health miniswine, a segment of internal jugular vein was anastomosed to the carotid artery as an interposition graft. Patency of swine major histocompatibility complex matched, one haplotype mismatched, and complete mismatched veins was 9.8, 6.3, and 3.0 weeks respectively (p = 0.009). More than 90{\%} of mismatched and 20{\%} of matched allografts developed a positive crossmatch before occlusion (p = 0.006). The mixed lymphocyte response did not predict graft occlusion. Treatment of 10 swine with cyclosporine (10 mg/kg/day) did not significantly improve patency for one haplotype mismatched grafts. In haplotype mismatched veins, cryopreserved grafts occluded more rapidly than noncryopreserved grafts: mean 2.4 versus 6.3 weeks, respectively (p = 0.002). In all cryopreserved vein grafts, alloantibody appeared at or after graft occlusion rather than before occlusion as seen with fresh allografts (p = 0.046). The mean patency of cryopreserved versus fresh autografts was 3.3 and >32 weeks, respectively (p = 0.004). In summary, these results indicate that (1) allograft patency is related to the degree of swine major histocompatibility complex match and development of cytotoxic alloantibodies; (2) moderate-dose cyclosporine does not prolong allograft patency nor suppress development of antibody; (3) cryopreservation may accelerate graft occlusion through nonimmunologic mechanisms.",
author = "Scott Stevens and Tyler, {John D.} and Michael Freeman and Fred Hopkins and Tammie Lewis and Joan Bray and Edwards, {Anne L.} and Kelvin Brockbank and Mitchell Goldman",
year = "1990",
month = "1",
day = "1",
doi = "10.1016/0741-5214(90)90161-3",
language = "English (US)",
volume = "12",
pages = "361--366",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Factors affecting patency of venous allografts in miniature swine

AU - Stevens, Scott

AU - Tyler, John D.

AU - Freeman, Michael

AU - Hopkins, Fred

AU - Lewis, Tammie

AU - Bray, Joan

AU - Edwards, Anne L.

AU - Brockbank, Kelvin

AU - Goldman, Mitchell

PY - 1990/1/1

Y1 - 1990/1/1

N2 - In immunologically defined National Institutes of Health miniswine, a segment of internal jugular vein was anastomosed to the carotid artery as an interposition graft. Patency of swine major histocompatibility complex matched, one haplotype mismatched, and complete mismatched veins was 9.8, 6.3, and 3.0 weeks respectively (p = 0.009). More than 90% of mismatched and 20% of matched allografts developed a positive crossmatch before occlusion (p = 0.006). The mixed lymphocyte response did not predict graft occlusion. Treatment of 10 swine with cyclosporine (10 mg/kg/day) did not significantly improve patency for one haplotype mismatched grafts. In haplotype mismatched veins, cryopreserved grafts occluded more rapidly than noncryopreserved grafts: mean 2.4 versus 6.3 weeks, respectively (p = 0.002). In all cryopreserved vein grafts, alloantibody appeared at or after graft occlusion rather than before occlusion as seen with fresh allografts (p = 0.046). The mean patency of cryopreserved versus fresh autografts was 3.3 and >32 weeks, respectively (p = 0.004). In summary, these results indicate that (1) allograft patency is related to the degree of swine major histocompatibility complex match and development of cytotoxic alloantibodies; (2) moderate-dose cyclosporine does not prolong allograft patency nor suppress development of antibody; (3) cryopreservation may accelerate graft occlusion through nonimmunologic mechanisms.

AB - In immunologically defined National Institutes of Health miniswine, a segment of internal jugular vein was anastomosed to the carotid artery as an interposition graft. Patency of swine major histocompatibility complex matched, one haplotype mismatched, and complete mismatched veins was 9.8, 6.3, and 3.0 weeks respectively (p = 0.009). More than 90% of mismatched and 20% of matched allografts developed a positive crossmatch before occlusion (p = 0.006). The mixed lymphocyte response did not predict graft occlusion. Treatment of 10 swine with cyclosporine (10 mg/kg/day) did not significantly improve patency for one haplotype mismatched grafts. In haplotype mismatched veins, cryopreserved grafts occluded more rapidly than noncryopreserved grafts: mean 2.4 versus 6.3 weeks, respectively (p = 0.002). In all cryopreserved vein grafts, alloantibody appeared at or after graft occlusion rather than before occlusion as seen with fresh allografts (p = 0.046). The mean patency of cryopreserved versus fresh autografts was 3.3 and >32 weeks, respectively (p = 0.004). In summary, these results indicate that (1) allograft patency is related to the degree of swine major histocompatibility complex match and development of cytotoxic alloantibodies; (2) moderate-dose cyclosporine does not prolong allograft patency nor suppress development of antibody; (3) cryopreservation may accelerate graft occlusion through nonimmunologic mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=0025142656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025142656&partnerID=8YFLogxK

U2 - 10.1016/0741-5214(90)90161-3

DO - 10.1016/0741-5214(90)90161-3

M3 - Article

VL - 12

SP - 361

EP - 366

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 3

ER -